Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
Gary S. Sachs, Paul Yeung, Ludmyla Rekeda, et al.
American Journal of Psychiatry (2023) Vol. 180, Iss. 3, pp. 241-251
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape
Manish K. Jha, Sanjay J. Mathew
American Journal of Psychiatry (2023) Vol. 180, Iss. 3, pp. 190-199
Closed Access | Times Cited: 58
Current Treatments for Depression
Maurizio Fava, John H. Krystal
Oxford University Press eBooks (2025), pp. 449-470
Closed Access
The real-world impact of cariprazine on short- and long-term disability outcomes among commercially insured patients in the United States
Prakash S. Masand, Mousam Parikh, Jamie T. Ta, et al.
Journal of Medical Economics (2025), pp. 1-29
Open Access
Myths of Randomized Controlled Trial Analysis in Pediatric Psychopharmacology
Jeffrey A. Mills, Jeffrey R. Strawn
Journal of Child and Adolescent Psychopharmacology (2025)
Closed Access
Safety and tolerability of cariprazine for the adjunctive treatment of major depressive disorder: a pooled analysis of phase 2b/phase 3 clinical trials
Michael E. Thase, Paul Yeung, Ludmyla Rekeda, et al.
International Clinical Psychopharmacology (2024)
Open Access | Times Cited: 4
Healthcare resource utilization and costs of using Cariprazine as the first versus subsequent adjunctive therapy for major depressive disorder
Prakash S. Masand, Anita H. Clayton, Mousam Parikh, et al.
Journal of Medical Economics (2025) Vol. 28, Iss. 1, pp. 235-244
Open Access
Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges
Michael J. Lucido, Boadie W. Dunlop
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 161-161
Open Access
Healthcare resource utilization with adjunctive cariprazine and other atypical antipsychotics in patients with major depressive disorder
Anita H. Clayton, Mousam Parikh, Tracy Yee, et al.
Current Medical Research and Opinion (2025), pp. 1-24
Closed Access
Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trial
Yongqin Ju, Wenwen Ou, Hao Chen, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
The augmentative efficacy of second-generation anti-psychotics (SGA) to anti-depressants in treating treatment-resistant depression: a network meta-regression analysis
Bing Bai, Yuwei Li, Xi Chen, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy
Robert Riesenberg, Paul Yeung, Ludmyla Rekeda, et al.
The Journal of Clinical Psychiatry (2023) Vol. 84, Iss. 5
Open Access | Times Cited: 9
Cariprazine in the acute treatment of unipolar and bipolar depression: A systematic review and meta-analysis
João Martins-Correia, Luís Afonso Fernandes, Ryan Kenny, et al.
Journal of Affective Disorders (2024) Vol. 362, pp. 297-307
Open Access | Times Cited: 3
Adjunctive cariprazine as a novel effective strategy for treating major depressive disorder: A systematic review and meta-analysis
Minjia Xie, Youjia Qiu, Menghan Wang, et al.
Journal of Psychiatric Research (2024) Vol. 172, pp. 71-80
Closed Access | Times Cited: 2
Adjunctive cariprazine for major depressive disorder: a systematic review and meta-analysis
Hartej Gill, David Chen‐Li, Sipan Haikazian, et al.
CNS Spectrums (2024) Vol. 29, Iss. 4, pp. 233-242
Closed Access | Times Cited: 2
Cariprazine augmentation in patients with treatment resistant unipolar depression who failed to respond to previous atypical antipsychotic add-on. A case-series
Enrico Pessina, Azzurra Martini, F. Raffone, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 6
A New Option for Depressed Patients Who Do Not Respond to Antidepressant Medications
Michael E. Thase
American Journal of Psychiatry (2023) Vol. 180, Iss. 3, pp. 188-189
Closed Access | Times Cited: 5
A Brief Review of Cariprazine
Sean E. Oldak, Maria Camila Chaparro, Laury Anne Jean-Paul
American Journal of Psychiatry Residents Journal (2024) Vol. 19, Iss. 3, pp. 6-8
Open Access | Times Cited: 1
Insights and Advances Into Treatments for Major Depression
Ned H. Kalin
American Journal of Psychiatry (2023) Vol. 180, Iss. 3, pp. 173-176
Closed Access | Times Cited: 2
Challenges of research on treatment‐resistant depression: a clinician's perspective
A. John Rush
World Psychiatry (2023) Vol. 22, Iss. 3, pp. 415-417
Open Access | Times Cited: 2
Role of adjunctive cariprazine for treatment-resistant depression in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials
Eman Ali, Fakhar Latif, Yusra Mashkoor, et al.
Asian Journal of Psychiatry (2024) Vol. 95, pp. 104005-104005
Closed Access
Clinical challenges in the dosing and titration of cariprazine
Čedo Miljević, Petar Vuković, Ana Munjiza
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Adjunctive cariprazine for the treatment of major depressive disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed
Leslie Citrome, Ivonna Reda, Majid Kerolous
Journal of Affective Disorders (2024)
Open Access
An “Awakener” Patient Suffering From Treatment-Resistant Depression Following Adjunctive Cariprazine
Konstantinos Bonotis
Cureus (2024)
Open Access
Prioritizing the Components of Any Decision-Making Model

Cambridge University Press eBooks (2024), pp. 276-307
Closed Access
Cariprazine: An Antipsychotic Medication with High Therapeutic Potential
Wiktoria Wilanowska, Anna Gregułą, Karol Stachyrak, et al.
Journal of Education Health and Sport (2024) Vol. 67, pp. 49405-49405
Open Access
Page 1 - Next Page

Scroll to top